Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Proteomic Analysis Reveals That the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Inhibits Megakaryopoiesis by Preventing Apoptosis

Michela Di Michele, Karen Peeters, Serena Loyen, Etienne Waelkens, Lutberg Overbergh, Marc Hoylearts, Christel Van Geet, MD, PhD, Kathleen Freson

Blood (2010) 116 (21): 4791.

https://doi.org/10.1182/blood.V116.21.4791.4791

Published: 2010

Journal Articles

PACAP: a new player in thrombopoiesis

Jorge Di Paola

Blood (2008) 111 (4): 1753–1754.

https://doi.org/10.1182/blood-2007-12-126151

Published: 2008

Journal Articles

PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications

Kathleen Freson, Karen Peeters, Rita De Vos, Christine Wittevrongel, Chantal Thys, Marc F. Hoylaerts, Jos Vermylen, Chris Van Geet

Blood (2008) 111 (4): 1885–1893.

https://doi.org/10.1182/blood-2007-06-098558

Published: 2008

Includes: Supplemental data

Journal Articles

Inhibition of VPAC1 Signaling Raises Platelet Numbers after Myelosuppressive Therapy and in GATA1 Congenital Thrombocytopenia.

Karen Peeters, Kathleen Freson, PhD, Christine Wittevrongel, Chantal Thys, Jean-Marie Stassen, PhD, Marc F. Hoylaerts, PhD, Chris Van Geet, MD PhD

Blood (2007) 110 (11): 1264.

https://doi.org/10.1182/blood.V110.11.1264.1264

Published: 2007

Journal Articles

Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury

Akira Arimura, Min Li, Vecihi Batuman

Blood (2006) 107 (2): 661–668.

https://doi.org/10.1182/blood-2005-03-1186

Published: 2006

Journal Articles

HIV-1 Proviral Integration Is Blocked by Agonists to the VpPAC2 Neuroendocrine Receptor.

Donald R. Branch, PhD, Payman Baradar Bokaei, MSc, Darinka Sakac, MSc, Xue-Zhong Ma, MD

Blood (2005) 106 (11): 1427.

https://doi.org/10.1182/blood.V106.11.1427.1427

Published: 2005

Journal Articles

VPAC1 Receptor-Mediated Regulation of Megakaryopoiesis.

Kathleen Freson, PhD, Chantal Thys, Christine Wittevrongel, Rita De Vos, PhD, Jos Vermylen, PhD, MD, Marc F. Hoylaerts, PhD, MD, Chris Van Geet, PhD, MD

Blood (2004) 104 (11): 735.

https://doi.org/10.1182/blood.V104.11.735.735

Published: 2004

NARROW

Proteomic Analysis Reveals That the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Inhibits Megakaryopoiesis by Preventing Apoptosis

PACAP: a new player in thrombopoiesis

PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications

Inhibition of VPAC1 Signaling Raises Platelet Numbers after Myelosuppressive Therapy and in GATA1 Congenital Thrombocytopenia.

Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury

HIV-1 Proviral Integration Is Blocked by Agonists to the VpPAC2 Neuroendocrine Receptor.

VPAC1 Receptor-Mediated Regulation of Megakaryopoiesis.

Email alerts

ASH Publications

American Society of Hematology

Proteomic Analysis Reveals That the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Inhibits Megakaryopoiesis by Preventing Apoptosis

PACAP: a new player in thrombopoiesis

PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications

Inhibition of VPAC1 Signaling Raises Platelet Numbers after Myelosuppressive Therapy and in GATA1 Congenital Thrombocytopenia.

Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury

HIV-1 Proviral Integration Is Blocked by Agonists to the VpPAC2 Neuroendocrine Receptor.

VPAC1 Receptor-Mediated Regulation of Megakaryopoiesis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only